October 9, 2012
A team of Spanish scientists has developed nanoparticles to selectively release therapeutic substances in aged human cells.
They are intended to treat diseases involving cellular degeneration of tissue, such as cancer, Alzheimer’s or Parkinson’s, among other accelerated aging pathologies.
The mesoporous nanoparticles contain galactooligosaccharide (a chemical normally used in probiotics, which are pills to stimulate growth of healthy bacteria).
The next step of this research is… read more